O’Brien Medical Obtains CE Mark Approval

The company is pleased to announce it’s flagship product, the ETF, has successfully passed the stringent laboratory test protocols required for CE marking.  Compliance with the safety and performance standards required for CE approval opens the way to planned international sales of the ETF in 2017. “We’ve had product inquiries from literally all over the world. The CE mark will open up some of those markets for us.” said CEO, Todd O’Brien. “It also speaks to the quality of our American-made product. Our manufacturer, Saunders Electronics, has done a superb job fabricating the ETF.”